Related Experiment Video

Updated: Oct 20, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.7K

PUM1 represses CDKN1B translation and contributes to prostate cancer progression

Xin Li1, Jian Yang1,2, Xia Chen1

  • 1State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Journal of Biomedical Research
|September 17, 2021
PubMed

Insights

Pumilio-1 (PUM1) is highly expressed in cancers, including prostate cancer, and drives tumor growth. Targeting the PUM1-CDKN1B axis offers a novel therapeutic strategy for cancer treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Posttranscriptional regulation is crucial in cancer development.
  • Pumilio-1 (PUM1), an RNA-binding protein, influences cell growth and proliferation.
  • PUM1 is implicated in various cancers, including prostate cancer.

Purpose of the Study:

  • To investigate the role of PUM1 in cancer, specifically its expression and function in prostate cancer.
  • To identify molecular targets regulated by PUM1 in tumorigenesis.
  • To explore the PUM1-CDKN1B interaction in prostate cancer.

Main Methods:

  • Analysis of PUM1 expression in diverse cancer types and prostate cancer tissues.
  • PUM1 knockdown experiments in prostate cancer cell lines.
  • Assessment of cell proliferation, colony formation, and tumor growth in vivo.
  • Investigation of PUM1's effect on cyclin-dependent kinase inhibitor 1B (CDKN1B) at mRNA and protein levels.

Main Results:

  • Human PUM1 is highly expressed in various cancers, correlating with reduced survival in prostate cancer patients.
  • Enhanced PUM1 expression was observed at both mRNA and protein levels in prostate cancer tissues.
  • PUM1 knockdown inhibited prostate cancer cell proliferation, colony formation, and tumor growth.
  • PUM1 regulates CDKN1B protein levels via translational control, not mRNA levels.

Conclusions:

  • PUM1 plays a critical role in prostate cancer cell growth and tumorigenesis through translational control.
  • The PUM1-CDKN1B regulatory axis is a key mechanism in prostate cancer.
  • This axis represents a potential therapeutic target for diverse cancers.
Keywords:
CDKN1BPUM1posttranscriptional regulationprostate cancer

More Related Videos

Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

46.3K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.5K